1 / 38

anaesthesia.co anaesthesia.co@gmail

Principles of Ophthalmic anesthesia, various drugs and their implications, surgeries and their concerns, MAC Moderator : DR RENU Presenter: DR SHAKTHI RAHUL. www.anaesthesia.co.in anaesthesia.co.in@gmail.com. Principles of ophthalmic Anesthesia. Safety

latif
Download Presentation

anaesthesia.co anaesthesia.co@gmail

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Principles of Ophthalmic anesthesia, various drugs and their implications, surgeries and their concerns, MAC Moderator : DR RENU Presenter: DR SHAKTHI RAHUL www.anaesthesia.co.inanaesthesia.co.in@gmail.com

  2. Principles of ophthalmic Anesthesia • Safety • Smooth induction • Akinesia • Profound analgesia • Avoidance or obtundation of oculomedulary reflex • Control of intraocular pressure • Awareness of drug interactions • Smooth emergence

  3. Oculo cardiac reflex First described by Bernard Aschner and Guiseppe Dagnini – 1908 Incidence up to 70-79% in ped. Ophthalmology (Allen et al. Eye,1998 ) Triggered by traction of extra ocular muscles , pressure on globe, intra orbital or retrobulbar injections

  4. Pathway

  5. …….. • Manifestations : Bradycardia : AV block :Ventricular bigeminy :Ventricular tachycardia (Alexender JP: Br J Ophth 1975 ) • Significant OCR –related bradycardia = 10-20 % decrease in resting heart rate , sustained for 5 secs or longer

  6. …… • Risk factors • Hypercarbia and hypoxemia • Inappropriate anesthetic depth • Surgery • Prevention • Avoid Hypercarbia and hypoxemia • Avoid Inappropriate anesthetic depth • Regional blocks • Topical lignocaine/ prilocaine/ proparacaine • Intravenous atropine/ glycopyrrolate ?

  7. Treatment : Release of stimulus : Increasing depth of anesthesia : Ventilatory status : Local anesthetics : Atropine/ glycopyrrolate When to start the surgery again ? Effect of repeated manipulation ?

  8. Intra ocular pressure • IOP is determined by • External pressure • Venous congestion • Changes in intraocular volume • Normal IOP 12-20 mm of Hg, abnormal above 22 mmHg • Newborn 9.5 mmHg, approximate adult pressure by 5 yrs of age • Open globe IOP – atmospheric pressure

  9. The effect of cardiac and respiratory variables on intraocular pressure (IOP)

  10. The effect of anesthetic agents on intraocular pressure (IOP)

  11. Strategies to prevent increases in intraocular pressure (IOP) • Avoid direct pressure on the globe • Patch eye with Fox shield • No retrobulbar or peribulbar injections • Careful face mask technique • Avoid increases in central venous pressure • Prevent coughing during induction and intubation • Ensure a deep level of anesthesia and relaxation prior to laryngoscopy • Avoid head-down position • Deep extubation

  12. HOW SUCCINYL CHOLINE INCREASES IOP • Mechanism : Tonic contraction of extra ocular muscle : Dilation of choroidal vasculature : Relaxation of orbital smooth muscle Calobrisi BL, Intanesthesiol Clin28:83,1990 • IOP ↑ in 1-2 min, peak 3 min, returns to normal after 4-6 min, ↑ up to 10-20 mmhg • Numerous methods for blunting Sx induced rise in IOP tried, results not consistent/ reliable

  13. Oculo respiratory Reflex • Afferent : Trigeminal nerve • Efferent : Pneumotaxic centers of the pons Medullary respiratory centers • Stimulus : pressure on the extra ocular muscles • Response : tachypnea or respiratory arrest ( Johnson and Frost , 1994 ) • Reflex not inhibited by atropine or glycopyrrolate

  14. Postoperative nausea and vomiting • Avg incidence in age above 3 yrs is above 30% (Rose and Watcha, BJA1999 ) • Untreated children after strabismus sx : 40-88% (Lerman,CJA1995 ) • Risk low below the age of 2 yrs

  15. Risk factors • Eberhart 2004 Surgery greater than 30 min, Age > 3 Strabismus surgery Previous history in patient/family • Other factors : gender, anesthetic technique, intraoperative opioids , inadequate pain control, gastric distension, skill of anesthesiologist ( Patel and Rice, 1991;Weinstein et al ,1994; Duncan,1995 ) • Oral fluid intake and early ambulation before discharge (ASA task force 2002 , Williams et al ,anesthesiology,2002)

  16. Intraoperative prophylaxisConsensus Guidelines for Managing PONV Anaesthesia Analgesia 2003; 97: 62-71.

  17. Prophylaxis • Clonidine premedication • Avoiding opioid analgesics • Dexamethasone ( 0.15 – 1mg/kg ) • 5 HT-3 antagonist ( Ondansetron, Granisetron) • Metoclopramide ( 100-250µg/kg) • Droperidol (10µg/kg )D.pptx • Withholding oral intake postoperatively • Hydration

  18. Transdermal scopolamine: 1.5mg 1hr prior to surgery (Anaes. Analg. 2007;104:92-96 ) Nonpharmacological • Acupuncture, acupressure and acupoint stimulation at P6 (Lee et al. Anes & Analg88:1362,1999) • Early positive results with Korean pressure point K 9 (BJA 2005;95:77-81.)

  19. Post operative apnea • Occurs more commonly in infants with prev h/o apnea ( Liu et al.,Anesthesiology59:506,1983) , younger than 42 to 44 weeks PC ( Malviya S, Anes & Anal.85:1207,1997), anemia • Although risk persist up to the age of 60 wks PC Kurth et al, Anesthesiology75:22-26,1991

  20. Cote et al study ( 1987 -1993) • CONCLUSION • Apnea strongly and inversely correlated both with gestational age and post conceptional age • An ass. risk factor was continuing episodes of apnea at home • SGA seemed to be some what protected from apnea compared with those with normal or LGA infants • Anemia( hematocrit < 30) was a significant risk factor even beyond 43 wks post conceptional age • Relationships of postoperative apnea with h/o NEC, neonatal apnea, RDS, BPD or operative use of opioids could not be determined

  21. Probability of apnea in non anemic, decrease with post conceptual and postnatal age but is not less than 5% until postconceptional age of 48 wks and not less than 1 % until postconceptional age of 56 wks • Should be monitored for al least 12 hrs postoperatively (Kurth et al. Anesthesiology66:483,1987) / 18-24 hrs (Liu et al .Anesthesiology59:506,1983 • Role of caffeine

  22. Premedication • Aims : To allay separation anxiety • Most commonly used drugs : Phenargan Diazepam Midazolam Clonidine Ketamine Triclofos

  23. ………… • Phenargan : Oral 1 mg/kg • Chloral hydrate : Oral 30-50 mg/kg : Rectal 30-50 mg/kg , max – 1 gm • Triclofos : Oral 25-30 mg/kg up to 1 gm • Topical local analgesia: EMLA cream takes 90min to be fully active

  24. Strabismus surgery • Prevalence: app. 3% population (Vivian, 2000) • Technique : recession or resection • Incidence increased with CNS dysfunction, oculomotor nerve trauma, sensory abnormality (cataract or refractive aberrations),various syndromes: Marfan syndrome, Down syndrome ,Homocystenuria, Goldenhar’s syndrome, Moebius syndrome, Stickler syndrome, Cri du chat syndrome, Apert’s syndrome )

  25. Concerns : Forced duction test : OCR : OER : Malignant hyperthermia : Ass. disease • General anesthesia : ETT/ LMA • Spontaneous/ controlled ventilation :controlled ventilation preferred (Blanc et al 1988)

  26. Forced duction test : helpful in differentiating between a paretic muscle and a restrictive force preventing ocular motion • Succinylcholine contraindicated in less than 20 mins of testing • NDMR preferred

  27. Malignant hyperthermia • One in 20,000 – 50,000 anesthetics, depending on drugs and location • One in 2,000 – 3,000 based on genetic testing • Rare in Infants • Incidence decrease after 50 yrs

  28. Triggering Agents for MH • Trigger agents • Halothane • Sevoflurane • Isoflurane • Desflurane - Succinylcholine • Non-trigger agents • Opioids • Non-depolarizing muscle relaxants • Ketamine • Propofol • Anxiolytics • Nitrous oxide

  29. Signs of MH • Specific • Tachycardia • Tachypnea • Acidosis • Hyperkalemia • Non-specific -Muscle rigidity • Increased CO2 production • Rhabdomyolysis • Marked temperature elevation

  30. Symptomatic Treatment of MH • Cooling Surface (ice, cooling blanket) • Central Intravenous iced saline • Nasogastric and rectal lavage • Intra-abdominal lavage • Cardiac bypass • Sodium Bicarbonate for metabolic acidosis • Management of hyperkalemia - insulin/glucose Diuretics - mannitol, lasix • Dantrolene

  31. Postoperative pain • Ass. with moderate pain • Mainstay NSAIDS • Acetaminophen : Rectal sup. 30-40 mg/kg loading dose, subsequent dose 20 mg/kg, interval 6-8hrs, 2 hrs required for peak plasma concentration : Oral 10-15 mg/kg every 4 hrs • Ibuprofen : 6-10 mg/kg , 6 hrly • Ketarolac : IM 0.75mg/kg, IV 0.5 mg/kg 6-8 hrly • Declofenac: 1- 1.5 mg sup. Repeated every 8 hrs

  32. Retinopathy of prematurity • Abnormal proliferation of undifferentiated primitive mesenchymal cells in the retina • Ass. With low birth weight, prematurity, neonatal high oxygen exposure, recurrent apnea • Incidence : 70% of extremely LBW (Moore, 2000) • Retinal tears and detachment may occur sec to contraction of the vitreous humour • Anes. Goals: PaO2 around 70 mmHg : SpO2 90- 95% : Prolonged exposure to high PaO2 to be avoided until PC 44 weeks. : Avoiding freq fluctuations in FiO2

  33. Vitroretinal surgery • Most commonly secondary to ROP, trauma and vitreous degeneration sec to some syndrome (Acute intermittent porphyria, Cystinosis, Homocystenuria, Hurler’s syndrome, Marfan syndrome, Stickler’s syndrome ) • Small amenable to laser therapies or cryopexy more sig. require sx. treatment

  34. Concerns : Akinesia : Proper control of IOP( mannitol, acetozolamide) :OCR :Silicone oil / long acting inert gases

  35. ……… • Intravitreal injection of gases: SF6, C3F8 • N2O rapidly enters from the gas bubble and increase the size of gas bubble • N2O should be discontinued at least 20 mins before • If pt require anesthesia again N2O should be avoided for 5 days for air injection, 10 days for SF6 injection, 30 days for perfluropropane • Avoidance of air travel

  36. Glaucoma • Prevalence , 1: 10,000 live birth • Congenital abnormality , inherited as AR, M>F • 10% ass. With systemic illness • Diagnosis : tonometry, corneal examination, fundoscopy and gonioscopy • Corrective procedures: Goniotomy, trabeculotomy, trabeculectomy and cyclocryotherapy

  37. Concerns : Stable IOP Akinesia Post operative pain PONV www.anaesthesia.co.inanaesthesia.co.in@gmail.com

More Related